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Sortase A is a transmembrane protein prominent in gram-negative bacterial strains. It is 
a virulence factor that anchors other proteins, which facilitate MRSA infections. In the 
long term, we plan to utilize this protein to create anti-infective drugs as antibiotic 
resistance continues to become a global health issue. Starting with five NIH drug 
candidates, we decided to first study Sortase A with B12 due to its historical past of 
ancient civilizations using natural sources of B12 to treat infections. Our senior design is 
further centered around understanding how vitamin B12 interacts with Sortase A in 
vitro, particularly the binding affinity between the two. The in vitro experiments will 
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Chapter 1: Introduction 
 
1.1 Background and Motivation 
 
The motivation of this project is to provide a more permanent solution to MRSA 
infections by surpassing the antibiotic resistance that antibiotics bring. The better 
quality of life and symptom reduction of MRSA patients is the ultimate motivation for 
this project. The objective of our senior design project is to test the molecular 
interactions between Vitamin B12 and protein virulence factors present on 
Methicillin-resistant Staphylococcus aureus (MRSA) bacteria . Ultimately, the main 
long-term goal of this project is to develop more effective drugs to treat MRSA. 
 
Overall, our senior design is centered on mechanism-based drug discovery. One of the 
particular strains that are of potential focus for this project is MRSA, which transitioned 
from a hospital-acquired infection to the community-acquired and livestock-acquired 
infections. The hair-like virulence factor on the gram-positive bacteria, specifically cilia 
or pili, are used for communication between cells. In this particular project, the 
cell-to-cell communications between gram-positive bacteria and mammalian (human) 
cells. Narrowing the already identified drug target library will help to identify Sortase 
A, which is an enzyme that catalyzes the anchoring and interactions of cell surface 
proteins.  
 
Patients who are suffering from MRSA will greatly benefit from the development of 
more effective gram-positive anti-infective drugs. This will allow patients to have a 
better lifestyle and will eventually have fewer restrictions on the family and the 





Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a type 
of ​Staphylococcus aureus​ gram-positive, round shaped bacteria that has become 
resistant to many of the antibiotics used to treat ordinary ​Staphylococcus aureus 
infections, including methicillin. (Siddiqui) Methicillin is an antibiotic ​β-lactam 
antibiotic​ of the ​penicillin​ class, which inhibits cell wall synthesis in bacteria. 
MRSA is resistant to many antibiotics and is therefore called a “superbug”. 
MRSA is the result of years of often unnecessary antibiotic use. Even when 
antibiotics are used appropriately, they contribute drug-resistant bacteria 
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because they do not destroy every bacterium they target. Bacteria live on an 
evolutionary fast track, so germs that survive treatment with one antibiotic soon 
learn to resist others. As a result, when one bacterium is resistant to an antibiotic 
it survives and divides rapidly and therefore, there is a dense population of 
bacteria that are resistant to antibiotics. These bacteria can also transfer the 
antibiotic resistant gene to other bacterial strains, which increases resistance to 
that antibiotic. 
 
MRSA is a bacterium that causes infection in different parts of the body. Usually, 
it causes a mild infection under the skin such as boils and sores. It can also cause 
serious skin infections and can cause infection in surgical wounds, bloodstream, 
lungs, or the urinary tract. Even though most infections of MRSA are not serious, 
some of these infections can be life threatening. The common ​Staphylococcus 
aureus​, like MRSA, start as swollen and painful red bumps that are possibly 
warm to the touch, have pus or other drainage, and accompanied by fever. Over 
time, they can turn into painful abscesses that require surgery to relieve the fluid 
and pain. If these infections are not on the surface of the skin, they can also cause 
infections in bone, joints, surgical wounds, bloodstream, heart valves, and the 
lungs. (Siddiqui, WebMD) 
 
Most MRSA infections occur in individuals who have been in hospitals or other 
health care settings. When it occurs in these settings, it's known as health 
care-associated MRSA (HA-MRSA). HA-MRSA infections are typically acquired 
from invasive procedures or devices, such as surgeries, intravenous tubing or 
artificial joints. With time, MRSA infections have occured in the community 
beyond hospitals. This is known as community-associated MRSA (CA-MRSA), 
which often begins as a painful skin boil. It is spread by skin-to-skin contact. 
(Zhang, Siddiqui)  
 
1.2 Existing Technologies 
 
Currently, anti-infectives is a new field that was started by Dr. Zhiwen Zhang, and 
there are no current anti-infective drugs on the market or under research. As of now, 
only antibiotics are available, and that is part of the problem due to antibiotic resistance. 
 
1.3 Literature Review 
 
Staphylococcus aureus Sortase A Exists as a Dimeric Protein In Vitro, Changsheng Lu, 
Jie Zhu,Yun Wang,Aiko Umeda,Roshani B. Cowmeadow,Eric Lai,Gabrielle N. 
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Moreno,Maria D. Person, and, and Zhiwen Zhang*, Biochemistry 2007 46 (32), 
9346-9354 DOI: 10.1021/bi700519w 
 
Simon G. Patching, Surface plasmon resonance spectroscopy for characterisation of 
membrane protein–ligand interactions and its potential for drug discovery,Biochimica 
et Biophysica Acta (BBA) - Biomembranes,,Volume 1838, Issue 1, Part A, 2014,, Pages 
43-55, 
ISSN 0005-2736, https://doi.org/10.1016/j.bbamem.2013.04.028. 
 
1.4 Project Goals 
 
The goals of this project included was to complete our research pipeline for developing 
the mechanism-based discovery assay. We initially started off with having a thorough 
understanding the basis of this project through literature review. Since, the project 
pertains to five potential NIH drug candidates that were tested in vivo with our protein 
target, it was important to understand which drug candidate we will be using to test the 
molecular interactions between Sortase A and our drug candidate. From, there we 
worked on planning how we would obtain Sortase A through protein purification. 
Ideally, we wanted to obtain a high-grade purified protein in order to reduce any false 
positive and false negatives that contaminants can produce when molecular interactions 
are tested. We also wanted to research about what instruments can be used for testing 
the molecular interactions between our Sortase A protein and our drug analyte.  
 
1.5 Alternative Solutions 
 
In order to prevent the spread of infection, wounds on the skin should be kept clean 
and covered with sterile, dry bandages. Washing hands after contact with an infected 
wound, dirty clothes, changing bandages is also recommended. Also, sharing personal 
items such as ​towels, washcloths, razors, and clothing can increase the chances of 
infection. Along with these preventative measures, there are ways of removing bacteria 
from the skin. ​Antibacterial body wash or powder for the skin (chlorhexidine baths), 
cream for inside the nose (if the infection is present there), antibacterial shampoo for the 
scalp (chlorhexidine soap shower/bath procedure), germ-killing soap and ointments can 
potentially remove bacteria from areas where they are in contact with the body. 
 
1.6 Team Management and Operations 
 
We started our project in September 2019 and will be concluding our experiments at the 
end of June 2019. We budgeted our time in Fall Quarter 2019 as well as Winter Quarter 
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2019 to optimizing our His-tag protein purification protocol. We then spent the bulk of 
Spring Quarter 2019 analyzing our protein samples via mass spectrometry and biacore. 
The majority of our budget was spent on various protein purification materials such as 
Ni-NTA beads, purification buffers and Qiagen reagents. We also used a quarter of our 
budget on SDS page gels and protein ladders in order to obtain better resolution in our 
gel results, which detailed the presence of our protein monomer and dimer.  
 
1.6.1 Senior Design Timeline 
 
Figure 1. Timeline and deadlines for Senior Design Project 2018-2019.  
 
1.6.2 Senior Design Budget  
 







Chapter 2: Collaborative Research  
 
We claim that there has been no collaborative research and would like to acknowledge 
as well as thank Santa Clara University for allowing us to research in the Alumni 

























Chapter 3: Project Outline and Design  
 
3.1 Cell Culture 
 
To make sure that we had an optimum amount of Sortase A protein to purify, we had to 
practice and become proficient in cell culture techniques. The cell culture protocol is 
completed in the span of three days. The first step is to transform ​E.coli​ cells with the 
pET-2b plasmid that contains the sequence for Sortase A with the 6-histidine tag. After 
the transformation is complete, the cells are grown on Agar plate with LB media for 48 
hours. A small 5 ml culture was created by growing these ​E.coli​ cells in the incubator 
shaker for 12 hours. After the small culture reached an OD of approximately 0.600, the 
small culture was transferred to 1500 ml of LB with Kanamycin to grow a larger culture. 
In this we also added IPTG to initiate induction, or the expression of Sortase A in the 
E.coli​ cells. After 6-8 hours of induction, the cell culture in the LB/Kanamycin solutions 
were placed in pre-weighed bottles and spun down in the centrifuge to filter out and 
get the cell pellets. The cell pellets plus bottles were weighed and stored in -80​o​C.  
 
3.2 Protein Purification 
 
3.2.1 Initial Native Protein Purification Protocol  
 
After our cell culture protocol, we needed to extract and further purify our 
protein. We first purified via Ni-NTA beads with buffers (wash, elution, lysis) 
that we had prepared. This protein purification method was centrifuge-based 
and needed to be optimized to ensure maximum protein yield. Throughout our 
optimization process, we needed to alter the time in which the cell solution was 
sonicated, the pH of the lysis buffer, wash buffer, as well as the elution buffer, in 
addition to the amount of time each consecutive solution was centrifuged to 
avoid protein denaturation. To further prevent protein degradation, PMSF was 
later added in small increments to our buffers.  
 




As a cross-comparison, we used the Qiagen Ni-NTA Native Protein Fast-Start 
Purification Kit to test for maximum protein yield. It should be noted that as 
opposed to our original protein purification procedure, the Qiagen kit provided 
us with spin columns and pre-made lysis buffers, elution buffers and wash 
buffers along with solutes that needed to be dissolved. To prevent protein 
degradation, we also added PMSF to each of the pre-made buffers.  
 
3.3 SDS Page Gel 
 
3.3.1 Changes and Specifications  
 
Initially, we used an SDS gel apparatus and gels from Bio-rad (Hercules, CA) to 
qualitatively test our protein purity. After multiple runs, we came to the 
conclusion that the Bio-rad products that we used did not reach the resolution 
that we desired in a gel image. Consequently, we decided to move on to use 
Invitrogen gels and an invitrogen apparatus (Carlsbad, CA), which enabled us to 
have a separation range of 10 kDa to 40 kDa. This allowed us to clearly see 
whether we had acquired the Sortase A monomer, which is located at the 17kDa 


















Chapter 4: Materials 
 
4.1 Cell Culture Materials 
 
The the kanamycin was obtained from VWR (Radnor, PA) and IPTG was obtained from 
US Biologicals. The rest of the materials such as the bottles and centrifuges were from 
the Bioengineering labs on campus.  
 
4.2 Protein Purification Materials 
 
Initially, we had started using the Qiagen protocol (Germantown, MD) that consisted of 
protein purification in the span of three days. This protein purification protocol was not 
as accurate when tested through the and therefore we switched to Qiagen’s Fast-Start 
Purification (Germantown, MD), which took 90 minutes. The Ni-NTA beads used for 
anchoring the Sortase A protein is from Qiagen. The PMSF used in the lysis buffer is 
also from Qiagen (Germantown, MD).  
 
4.3 SDS Page Gel Materials 
 
The protein ladder was obtained from invitrogen (Carlsbad, CA). This was used to 
calibrate and make sure that we can identify the protein qualititatively. Initially, we had 
used Bio-Rad (Hercules, CA) apparatus to run the gel, but due to compatibility issues 
with the protein ladder, samples, and gel, we transitioned to the Invitrogen apparatus 
(Carlsbad, CA). The running buffer and SDS Page Gel were also from Invitrogen to 
make sure that there was consistency in the data (Carlsbad, CA).  
 
4.4 Mass Spectrometry Materials 
 
Mass spectrometry, also known as MALDI-TOF, utilized materials (buffers, solutes) and 








Chapter 5: Methods  
 
5.1 LB & Agar Plate Preparation  
 
We first needed to autoclave 2000 mL Erlenmeyer flask under gravity (solid) conditions. 
Next, we made 500 mL of an LB and agar mixture by weighing out 7.5 g of Agar and 
12.5 g of LB. We poured the weighted LB and Agar into our autoclaved Erlenmeyer 
flask. We filled the Erlenmeyer flask with 500 mL of di-water and Mixed solution until 
the LB and Agar completely dissolved. Afterwards, we autoclaved the LB + Agar 
solution under liquid conditions for about 45 minutes and allowed it to cool once 
finished. An addition of 250 uL of Kanamycin was finally added to the solution for 
plasmid selection. For safety purposes, we then mixed the solution in a sterile 
environment by wiping down surface and pipets with 70% ethanol and lighting an 
alcohol burner. After lighting the alcohol burner, we poured 10-15 mL of solution into 
each lab plate. We allowed the plates to solidify for 1 hour in sterile environment with 
the lid half-way open and placed the lid over the plates and let the plates sit in sterile 
environment upside-down for 1 hour. It is important to parafilm each plate and store it 




We thawed the DNA vector and the Invitrogen - One shot Top10 Chemical Competent 
E.coli​ kit on ice. We added 5 uL of DNA vector sample into competent cells. We mad 
sure not to pipet mix the DNA vector sample into competent cell and gently tapped the 
tube to mix. We heat-shocked the sample by placing them in a water bath set at 42 
degrees Celsius for 30 seconds. The sample is then placed on ice for another 30 seconds. 
Then, 250 uL of prewarmed Super Optimal Broth with Catabolite Repression (SOC) 
media at 37 degrees Celsius to the sample and store them in the 4 degrees Celsius 
fridge. 
 
5.3 Plating Transformed Cells  
 
Starting in a sterile environment, we pipetted 50 uL of transformation solution onto the 
center of the LB + Agar plate. We then used a sterile pipet tip to spread the sample 
around the LB + Agar plate while keeping the plate close to the alcohol burner. The 
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sample plate was then covered with a lid and stored upside-down in an incubator set at 
37 degrees celsius. The colonies were allowed to grow for roughly 48 hours on average. 
After the growth period, the sample plates were stored in a four degree refrigerator.  
 
5.4 Creating Small Scale Culture 
 
A 2000 mL Erlenmeyer flask was autoclaved under gravity (solid) conditions. We 
created 500 mL of LB by weighing out 12.5 g of LB. The measured LB was poured into 
the autoclaved Erlenmeyer flask. The Erlenmeyer flask was filled with 500 mL of 
di-water and mixed in solution until the LB completely dissolve. The  LB solution was 
autoclaved under liquid conditions. We waited until the the LB solution cooled down to 
room-temperature and then added 1:100 to 1:50 ratio of Kanamycin. We mixed the LB 
solution, so that Kanamycin is distributed throughout the solution. We pipetted 5 mL 
from the LB solution into a separate cell culture tube. Then, we collected the LB + Agar 
plate with colonies from 4 degrees Celsius fridge and used a sterile loop or pipet tip to 
pick a colony and inoculated it in the 5 mL in a sterile environment. We placed the 5 mL 
small scale culture in a shaking incubator at 225 rpm at 37 degrees Celsius. The  5 mL 
small scale culture grow for 26 hours. The big scale LB solution in the Erlenmeyer flask 
was parafilmed and store in 4 degrees Celsius fridge. The OD of the 5 mL small scale 
culture was monitored on the spectrophotometer. We used plain LB without kanamycin 




5.5 Large-Scale Culture  
 
When the OD for the small scale culture was neat 1, we added the culture to a 1500 mL 
kanamycin and LB solution. The large scale culture was then left in the shaking 
incubator at 225 rpm at 37 degrees celsius for roughly 8 hours. Once the OD of the 
culture reached 0.6, we collected one milliliter of the cell solution as a negative control 
for SDS page steps in the future. Next, we added IPTG at a final concentration of 0.1 
mM to induce cell growth. From this point, our large-scale culture was incubated at 225 
rpm at 37 degrees celsius for 15-20 hours.  
 
5.6 Qiagen Native Protein Purification Kit  
 
Before starting the experient, the native Lysis Buffer must be prepared. The lysis buffer 
must consist of lysozyme and Benzonase Nuclease. The contents of the lysozyme vial 
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are dissolved in 600 µl of native Lysis Buffer. To create a 10 ml aliquot of native Lysis 
Buffer, 100 µl of the lysozyme solution is added. If not used immediately, the remaining 
lysozyme solution is stored at –20°C. The vial containing Benzonase® Nuclease solution 
is thawed and 10 µl is added to the 10 ml aliquot of native Lysis Buffer. The cell pellet is 
thawed for 15 min on ice and resuspended in 10 ml of native Lysis Buffer. They are 
incubated on ice for 30 minutes and mixed 2–3 times by gently swirling the cell 
suspension. The lysate is centrifuged at 14,000 x g for 30 minutes at 4°C to pellet the 
cellular debris. The cell lysate supernatant is retained. The supernatant now contains 
the soluble fraction of the recombinant protein. The resin is gently resuspended tin a 
Fast Start Column by inverting it several times. The seal was broken at the outlet of the 
column and the screw cap was opened, allowing the storage buffer to drain out. The 
outlet seal must be broken before the screw cap is removed. The cell lysate supernatant 
is applied to the column. The flow-through fractions are collected. The column was 
washed twice with 4 ml of native Wash Buffer. Both washes were collected. The bound 
6xHis-tagged protein was eluted with two 1 ml aliquots of Native Elution Buffer. Each 
elution fraction was collected in a separate tube. All fractions collected were stored in 
-20 degrees Celsius and analyzed by SDS page Gel Electrophoresis. 
 
 
5.7 SDS Page Gel Electrophoresis 
 
First, we started by collecting our stored supernatents from a -20 degrees celsius and 
placing them all on ice to thaw out slowly. Once they were ready, we used a nanodrop 
to find the concentrations of each of the different supernatants, which included two 
washes and two elutions. For the nanodrop, wash buffer was used as a blank for the 
Flow Through and the six washes. The Elution Buffer was used as a blank for the two 
Elutions. The 26616 Protein MW Ladder and 5X dye was used. Separate samples to run 
through SDS-Page gel were loaded on the gel. Each sample consisted of 48 uL of specific 
sample and 12 uL of 5X dye, with the total volume of 60 uL. One liter of Running Buffer 
was med by mixing the Running Buffer Powder in 1 L of di-water. We set up the 
SDS-Page apparatus and poured the running buffer to overfill the gel and make sure 
the running buffer is filled up to the 2 gel mark. The prepped samples were loaded on 
the gel. The ladder and samples, 7 uL and 60 uL respectively, were loaded. The running 
buffer was pipetted back into the gel if needed. The SDS-Page apparatus was connected 
to the Power Box and we ran it at 110 V for 50 minutes. After running the gel, the Power 
Box was turned off Power Box and we disconnected the SDS-Page apparatus. The 
running buffer was poured in a container and stored for later use —it can be used a 
total of 3 times. The plastic sheets around the gel were removed the gel was rinsed with 
di-water. The gel was placed in a container of di-water and microwaved for 20-30 
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seconds. The di-water was poured out  and the container was filled with LabSafe Gel 
Blue. The gel was stained for 1 hour unders the incubator shaker. After 1 hour, the the 
LabSafe Gel Blue was poured in an Erlenmeyer flask and parafilmed. The LabSafe Gel 
Blue can be used a total of 2 times. The gel container was filled with di-water and 
destained overnight under the incubator shaker. The next day, the gel was screened in 
the LAS 500 imager. The images were saved and analyzed and the gel was stored in 





































Chapter 6: Results and Discussion  
 
We were able to verify the presence of Sortase A via SDS page gel and MALDI-TOF. 
This in turn verified that we were able to successfully purify Sortase A. Prior to the 
verification process with SDS page gel and MALDI-TOF, we sequenced our purified cell 
plasmid to verify that our cells were capable of expressing the gene for Sortase A 
production. We translated our DNA sequence to a protein sequence, and later found 
portions of the Sortase A sequence within our own protein sequence. This sequence, 
and the subsequent weight of Sortase A, is shown in Figure X. As shown below in 
Figure X, we were then able to verify that the 17 kDa band, associated with the 
monomer for Sortase A, and the 34 kDa band, associated with the dimer for Sortase A, 
were both present throughout the gel. Lastly, in Figure X, we were able to observe a 
peak for Sortase A based on its weight. Overall, our results were significant as we were 
able to successful isolate and purify Sortase A in order to test its interaction with B12, 
and later the four other NIH drug candidates. 
 




Figure 3:​ SDS Page Gel Final Result  
 
 








Chapter 7: Project Challenges 
 
7.1 Purification Process 
 
The most challenging step of our project was the purification of Sortase A protein. We 
dedicated the majority of our time in lab purifying Sortase A and with our advisor 
troubleshooting the protein purification procedure and materials. We encountered 
challenges working with delicate instruments in lab that required specialists and lab 
managers to train us and calibrate the instruments. In order to improve the purification 
process and find the specific step that needed to be optimized, we troubleshooted the 
procedure into three main steps:  Cell growth and protein expression, protein 
purification and analysis.  
 
7.2 Qiagen protocol  
 
The Qiagen Protocol 9. Preparation of cleared ​E. coli ​lysates under native conditions 
[cite] was used for our protein purification process as the starting point. There were also 
previous students purification protocol notes that we used. Since we did not obtain 
meaningful results on the first purification experiment, we decided discussed possible 
variations on materials and methods to achieve optimum results. This troubleshooting 
process was repeated several times during this project. 
 
7.2.1​ E. coli ​cells and cell growth 
In order to identify transformed cells, we used competent ​E. coli 
cells transformed with the plasmid pET2b. Since there were no 
information if the cells were expressing Sortase A and which plates 
were growing cells expressing (C) His6 tag or (N) His6 tag, we 
decided to sequence the cell via a purified plamid. Initially, our 
goal was to use the (N) His6 tag growing cells but we were only 
able to confirm (C) His6 tag expressing cells.  
 
7.2.1.1: Sequencing 
In order to confirm we had the two variations of cells, we used Sequetech 
sequencing services. We were able to confirm the number two which is a 
C end his6 tag after analysing the amino acid sequence. Having this 
confirmation gave us confidence that we were growing the right cells and 
that they were expressing Sortase A. In order to find the location of His6 
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tag, we used exPasy and located the string of six histidine amino acids, 
confirming that they were on the (C) end. Once we confirmed the cells, we 
had and therefore which plasmid had been used to transform these cells, 
we were also able to confirm the promoter which had been induced with 
the correct reagent, IPTG. 
 
7.2.1.2 Cell growth and protein expression 
 
7.2.1.2.1 Kanamycin  
 
We used the diluted and aliquoted kanamycin that was available in 
our lab. Because the eppendorf tubes of aliquoted kanamycin had 
no dates or information about the antibiotic, we purchase 
kanamycin in solid form and reconstituted to the concentration we 
needed. We suspected that the kanamycin we had used from the 




Similarly, we suspected that the IPTG we were using in lab from 
previous projects were expired and no longer effective. We 




In order to prevent Sortase A degradation during the sonication 




Sonication is an important step to help lyse the cells in order to 
obtain the Sortase A which in embedded in the cell membrane. The 
recommended instructions that we obtained from previous 
experiments were to set the sonicator to alternate from 10 seconds 
of sonication and 15 seconds of resting period for 20 cycles with 
amplitude of 30%. Our advisor suggested that we sonicated for a 
longer period of time (1 hr), by giving a longer period of rest (three 
minutes) to allow the lysate to cool since the heat generated from 
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sonication can degrade proteins. We found that 30 cycles of 15 
seconds of sonication and 50 seconds of rest period worked best. 
Color difference in the lysate was noted as the lysate that sonicated 
for a longer period of time appeared to have a more yellow color 
than the previous lysates that were more clear color.  
 
7.2.1.3 Purification Steps 
 
7.2.1.3.1 Imidazole Concentration 
 
The purpose of imidazole is to increase the purity by either 
promoting binding of Sortase A or minimizing binding of 
unwanted proteins depending on its concentration in each of the 
three buffers. Imidazole has similar structure to histidine and 
excessive concentrations can denature proteins. Initially, imidazole 
concentration for lysis buffer was 10mM , for wash buffer was 
20mM and for elution buffer was 250mM according to Qiagen. We 
first adjusted to 10mM for the elution buffer and no imidazole on 
washing and lysis buffer. No improvement on the results were 
noted. We also tried increasing the lysis buffer imidazole 
concentration from 10mM to 15mM, but no difference was 
observed. therefore the initial Qiagen protocol concentrations were 
maintained. 
 
7.2.1.3.2 pH adjustment 
 
The pH also plays a role in the binding affinity of proteins. Values 
of pH above 10 or below 5.8 are not ideal. According to Qiagen 
protocol, optimum pH value is 8.0 for lysis, wash and elution 
buffers. We tested by changing pH to 8.5 for lysis buffer to help 
lysing the cells. Without observing any changes in the results, we 
kept the Qiagen recommended pH 8.0 for all three buffers. 
 
7.2.1.3.3 Ni-NTA Beads Binding Time 
 
We varied the binding time from two hours to four hours and also 
tried binding overnight (eight to ten hours). For longer binding 
periods, we also increase the time for the rotator in the washing 
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step. For the overnight binding, the last wash (wash 6) was 
adjusted for one hour in the rotator before centrifuge step.  
 
7.2.1.3.4 Qiagen Fast-Start Purification Kit 
 
After several experiments following the Qiagen protocol and 
preparing our own buffers, we decided to try a purification kit 
from Qiagen to save us time and allow us to obtain a high yield of 
Sortase A for our experiments. The kit was certainly an 
improvement and a quicker purification process. Although it 
produced better results, the yield was not very significant. 
 
7.2.1.3.5 Coomassie Blue 
 
In order to get a clearer contrast on the SDS PAGE gel imaging and 
improve the quality of the gel staining, we chose to use coomassie 
Blue staining instead of common blue dye. The blue dye was 
further more easily contaminated and it was not as sensitive in 
terms of staining. As we have later found, Coomassie blue staining 
methods resulted in clearer resolution and greater band visibility.  
 
7.2.1.3.6 Maldi-TOF calibration 
 
In our second experiment analysing our purified protein, we had 
no meaningful results from the Maldi-TOF mass spec analysis. The 
specialist was there at the time and he warned us that the 
equipment needed to be calibrated, and therefore these results were 
maybe incorrect. The Maldi-TOF was calibrated and also needed 
some maintenance before we could rerun our analysis. It took 
















We wanted to make sure that the resources and materials were used efficiently in order 
to ensure that we use our budget effectively. We kept a track of the materials we used 
by recording the cost of each material and when it was purchased.  
 
8.2 Health and Safety 
 
The engineering standards for this project were followed based on Santa Clara 
University’s guidelines. Health and safety in the bioengineering labs at Santa Clara 
University were implemented at all times. This was achieved through maintaining 
laboratory standards and following protocols to maintain sterility in the lab to make 
sure that there was no cross contamination. Public health considerations were also 
taken into account by making sure that different types of wastes were disposed using 
the correct protocols. Laboratory safety protocols, training for laboratory instruments, 




In order to ensure that we are sustainable in what we use, we made sure that we used 
efficient instruments that did not use extra power. Moreover, we followed the 
biohazard waste and disposal protocols and laboratory protocols to make sure that we 










Chapter 9: Ethical Considerations 
 
9.1 Team Ethics 
 
Having a high standard of work ethics was the first priority. As a team, the work was 
distributed to increase efficiency and everyone had a clear communication with each 
other. There was honesty, sincerity, and hardwork in this project. Moreover, as a team, 
we made sure to be cognizant about how the resources were allocated for this project in 
order to stay within the budget of the grant. The two main priorities were working 
effectively and ensuring the well-being and development of the team over time. This 
included listening to each other, being respectful, and making sure that we 




We also used ​E.coli​ bacterial strains instead of MRSA strains to avoid any contamination 
and unintended infections. Moreover, we wanted to take precautionary measures to 
maintain safety in the bioengineering labs by sterilizing all of the glassware and lab 
benches before use.  Cleaning methods were implemented to avoid contamination 
when other experiments are performed in the lab with those materials. In this way, we 
wanted to reduce the amount of cross contamination and wanted to develop a more 


















While our contribution to the anti-infective development was not the noteworthy, 
purifying and isolating Sortase A was the one of the most difficult portions of the 
process as there were constant challenges such as protein degradation, cell culture 
instability, and cell line mutations. Having a purified Sortase A protein reduces the false 
positives when testing for the interactions between Sortase A and the Vitamin B12 drug 
candidate. 
 
10.2: Next Steps  
 
10.2.1 ​Fast Protein Liquid Chromatography (FPLC) 
 
Fast Protein Liquid Chromatography is a type of liquid chromatography  to 
analyze a heterogenous mixture of protein samples. Our Sortase A protein can be 
purified further in order to get more accurate results and better interactions with 




Biacore is a surface plasmon technology (SPR) that monitors molecular binding 
events in real time. It is useful to measure the binding affinities, 
thermodynamics, and kinetic rate constants. Once the Sortase A protein is 
purified further, pur next steps is to test how our protein interacts with the 
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